Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CDK5 ELISA Kit (AC2593)
Cat.#: ASET-1182
Specifications
Description Human CDK5 ELISA Kit allows for the in vitro quantitative determination of human CDK5 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1261 Rat AKR7A2 ELISA Kit (AC2672) Quantitative inquiry ASET-2506 Bovine Antidiuretic Hormone ELISA Kit (AC3917) Quantitative inquiry ASET-2193 Human Robo4 ELISA Kit (AC3604) Quantitative inquiry ASET-2130 Rat Adenosine Receptor A2a ELISA Kit (AC3541) Quantitative inquiry ASET-1689 Human GABA A Receptor alpha 1 ELISA Kit (AC3100) Quantitative inquiry ASET-1992 Porcine BDNF ELISA Kit (AC3403) Quantitative inquiry ASET-1575 Human KCNK9 ELISA Kit (AC2986) Quantitative inquiry ASET-1087 Rat Dystrophin ELISA Kit (AC2498) Quantitative inquiry ASET-1521 Porcine eNOS ELISA Kit (AC2932) Quantitative inquiry ASET-1751 Human TNR ELISA Kit (AC3162) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket